| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 06/18/2009 | US20090155903 Pharmaceutical composition and method |
| 06/18/2009 | US20090155203 Thrombopoietin mimetics |
| 06/18/2009 | US20090153034 Carbazole-containing materials in phosphorescent light emittinig diodes |
| 06/18/2009 | CA2709314A1 5-alkyl/alkenyl-3-cyanopyridines as kinase inhibitors |
| 06/18/2009 | CA2709288A1 Indole-substituted 3-cyanopyridines as kinase inhibitors |
| 06/18/2009 | CA2709203A1 Hedgehog pathway antagonists and therapeutic applications thereof |
| 06/18/2009 | CA2708741A1 Bis-pyridylpyridones as melanin-concentrating hormone receptor 1 antagonists |
| 06/18/2009 | CA2708706A1 Cannabinoid receptor modulators |
| 06/18/2009 | CA2708303A1 Cyclic urea inhibitors of 11.beta.-hydroxysteroid dehydrogenase 1 |
| 06/18/2009 | CA2707492A1 Gamma secretase modulators |
| 06/18/2009 | CA2707313A1 Novel heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| 06/18/2009 | CA2707047A1 Carboxamide, sulfonamide and amine compounds for metabolic disorders |
| 06/18/2009 | CA2706679A1 Novel compounds 010 |
| 06/18/2009 | CA2700559A1 Nicotinamide derivatives, preparation thereof and therapeutic use thereof |
| 06/17/2009 | EP2070934A1 Synthesis of biguanidines and triazines, and biguanidino-aluminium complexes as intermediates |
| 06/17/2009 | EP2070922A1 Azabicyclo(3.1.0) hexane derivatives useful as modulators of dopamine D3 receptors |
| 06/17/2009 | EP2070921A1 Indolylmaleimide derivatives as protein kinase c inhibitors |
| 06/17/2009 | EP2070920A1 Substituted 2-(2,6-dioxopiperidin-3-yl)-phthalimides and 1-oxoisoindolines and method of reducing TNF alpha levels |
| 06/17/2009 | EP2070914A1 New antagonist derivatives of the vitronectin receiver, method for preparing same, application of same as medicine and pharmaceutical compositions containing them |
| 06/17/2009 | EP2069345A2 Pyridazine and pyrrole compounds, processes for obtaining them and uses |
| 06/17/2009 | EP2069333A1 Pyrrole derivatives useful for the treatment of cytokine-mediated diseases |
| 06/17/2009 | EP2069330A1 2 -benzimidazolyl- 6 -morpholino-4- (azetidine, pyrrolidine, piperidine or azepine) pyrimidine derivatives as pi3k and mtor inhibitors for the treatment of proliferative disorders |
| 06/17/2009 | EP2069329A2 A process for the preparation of benzimidazole derivatives and their salts |
| 06/17/2009 | EP2069328A2 4-arylalkoxymethyl-4-phenyl piperidines and their use as neurokinin receptor antagonists for the treatment of cns disorders |
| 06/17/2009 | EP2069327A1 New pyridone derivatives with mch antagonistic activity and medicaments comprising these compounds |
| 06/17/2009 | EP2069326A2 Bicyclic and tricyclic derivatives as thrombin receptor antagonists |
| 06/17/2009 | EP2069325A2 Isoquinoline, quinazoline and phthalazine derivatives |
| 06/17/2009 | EP2069324A1 Fused amino pyridine as hsp90 inhibitors |
| 06/17/2009 | EP2069316A1 2,4-diaminoquinazolines for spinal muscular atrophy |
| 06/17/2009 | EP2069314A1 Pyrimidines derivatives and their use as kinase inhibitors |
| 06/17/2009 | EP2069313A2 Metalloprotease inhibitors |
| 06/17/2009 | EP2069310A2 Sulfonylpyrazoline carboxamidine derivatives as 5-ht6 antagonists |
| 06/17/2009 | EP2069308A2 Azonafide derived tumor and cancer targeting compounds |
| 06/17/2009 | EP2069305A2 Nicotinic acid derivatives as modulators of metabotropic glutamate receptors |
| 06/17/2009 | EP2069303A2 Antiviral protease inhibitors |
| 06/17/2009 | EP2069302A1 Substituted pyridylmethyl bicyclocarboxyamide compounds |
| 06/17/2009 | EP2068632A1 Fungicides |
| 06/17/2009 | EP1836166B1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 06/17/2009 | EP1789419B1 Gyrase inhibitors and uses thereof |
| 06/17/2009 | EP1789410B1 Methylene dipiperidine derivatives |
| 06/17/2009 | EP1656365B1 A method for the preparation of enantiomerically pure mirtazapine |
| 06/17/2009 | EP1590341B1 2-aminopyridine substituted heterocycles as inhibitors of cellular proliferation |
| 06/17/2009 | EP1565431B1 Cannabinoid receptor ligands |
| 06/17/2009 | EP1542990B1 Novel imidazole compounds as transforming growth factor (tgf) inhibitors |
| 06/17/2009 | EP1485375B1 Pyrimidine compounds |
| 06/17/2009 | EP1472230B1 Ansamycins having improved pharmacological and biological properties |
| 06/17/2009 | CN101460486A Succinate salts of 6-methoxy-8-[4-(1-(5-fluoro)-quinolin-8-yl-piperidin-4-yl)-piperazin-1-yl]-quinoline and crystalline forms thereof |
| 06/17/2009 | CN101460485A Azabicyclo [3. 1. 0] hexyl derivatives as modulators of dopamine D3 receptors |
| 06/17/2009 | CN101460484A 6-methoxy-8-[4-(1-(5-fluoro)-quinolin-8-yl-piperidin-4-yl)-piperazin-1-yl]-quinoline hydrochloric acid salts |
| 06/17/2009 | CN101460483A Benzoimidazol-2-yl pyrimidines and pyrazines as modulators of the histamine H4 receptor |
| 06/17/2009 | CN101460482A Heterocyclic substituted pyridine compounds with CXCR3 antagonist activity |
| 06/17/2009 | CN101460481A Novel method for preparation of ammonium salts of esomeprazole |
| 06/17/2009 | CN101460480A 2-aminopyrimidin-4-ones and their use for treating or preventing a beta-related pathologies |
| 06/17/2009 | CN101460479A 3-(pyridin-2-yl)-[1,2,4]-triazines for use as fungicides |
| 06/17/2009 | CN101460478A Novel bi-aryl amines |
| 06/17/2009 | CN101460477A Novel indazole derivative having spiro ring structure in side chain |
| 06/17/2009 | CN101460476A Organic compounds |
| 06/17/2009 | CN101460475A 2-(pyridin-2-yl)-pyrimidines for use as fungicides |
| 06/17/2009 | CN101456841A Amide derivative and medicine |
| 06/17/2009 | CN100500661C Method for purifying 1-(5-nitro-III-indole-2-carbonyl)-4 {3-[(1-methyl-ethyl)-amino]-2-pyridine} ethylene imine |
| 06/17/2009 | CN100500660C Process for preparing (s)-pantoprazole |
| 06/17/2009 | CN100500654C Tetrahydrocarbazol derivatives as ligands for g-protein-coupled receptors (gpcr) |
| 06/16/2009 | US7547800 Process for trans-4-amino-1-cyclohexanecarboxylic acid derivatives |
| 06/16/2009 | US7547782 Met kinase inhibitors |
| 06/16/2009 | US7547779 Preparation of 1,6-disubstituted azabenzimidazoles as kinase inhibitors |
| 06/16/2009 | US7547722 Chemical compounds |
| 06/16/2009 | US7547717 2-thioxo-4-imidazolines; angina, hypertension, congestive heart failure, myocardial ischemia, arrhythmia, diabetes, urinary incontinence, stroke, pain, brain injury, or neuronal disorders |
| 06/16/2009 | US7547712 Reducing adverse effect of nicotine on fetus by administering a nicotine-carrier conjugate to a human pregnant with a fetus, wherein carrier is an immunogenic protein, and wherein adverse effect is selected from low birth weight, premature delivery/birth, post-natal nicotine withdrawal |
| 06/16/2009 | US7547710 Such as (2E)-3-[3-(aminomethyl)-2-isobutyl-4-(4-methylphenyl)quinolin-6-yl]acrylamide; dipeptidyl peptidase IV inhibitors; diabetes, obesity, glucose intolerance |
| 06/16/2009 | US7547707 Spirocyclic cyclohexane compounds |
| 06/16/2009 | US7547702 Glycoprotein antagonist; anticholesterol agents; cardiovascular disorders; strokes; antiischemic agents |
| 06/16/2009 | US7547700 Such as (3-chloro-4-fluorophenyl)(4-fluoro-4-{[(5-hydoxypyridin-2-ylmethyl)amino]methyl}piperidin-1-yl)methanone; serotonin receptor agonists; for treating depression, pain, and substance abuse |
| 06/16/2009 | US7547693 Piperidine derivative |
| 06/16/2009 | US7547660 Phenyl-substituted 4-hydroxy-tetrahydropyridones |
| 06/16/2009 | US7547274 Radioactive member and method of making |
| 06/16/2009 | CA2452217C Hiv inhibiting pyrimidines derivatives |
| 06/16/2009 | CA2451474C Triamide-substituted indoles, benzofuranes and benzothiophenes as inhibitors of microsomal triglyceride transfer protein (mtp) and/or apolipoprotein b (apo b) secretion |
| 06/16/2009 | CA2381097C Arylmethyl-carbonylamino-thiazole derivatives and their use as antitumor agents |
| 06/16/2009 | CA2357744C Potassium salt of (s)-omeprazole |
| 06/11/2009 | WO2009073779A1 Gamma secretase modulators |
| 06/11/2009 | WO2009073203A1 Trp-m8 receptor ligands and their use in treatments |
| 06/11/2009 | WO2009072649A1 4-arylphenyl derivative |
| 06/11/2009 | WO2009072643A1 Nitrogen-containing heterocyclic compound and use thereof |
| 06/11/2009 | WO2009072581A1 Lactam compound or salt thereof, and ppar activator |
| 06/11/2009 | WO2009071701A1 Pyrazole derivatives and use thereof as inhibitors of cyclin dependent kinases |
| 06/11/2009 | WO2009071689A2 5-halogen-substituted oxindole derivatives and use thereof for treating vasopressine-dependent diseases |
| 06/11/2009 | WO2009071687A1 Amidomethyl-substituted oxindole derivatives and the use thereof for the treatment of vasopressin-dependent illnesses |
| 06/11/2009 | WO2009071677A1 New compounds iii |
| 06/11/2009 | WO2009071535A1 Diaminopyridines for the treatment of diseases which are characterised by excessive or anomal cell proliferation |
| 06/11/2009 | WO2009071509A1 1,2-disubstituted-4-benzylamino-pyrrolidine derivatives as cetp inhibitors useful for the treatment of diseases such as hyperli pidemia or arteriosclerosis |
| 06/11/2009 | WO2009071504A1 2,6-disubstituted pyridines as soluble guanylate cyclase activators |
| 06/11/2009 | WO2009071483A1 1- (indaz0l-5-yl) -ureas as diacylglycerol acyltransferase inhibitors |
| 06/11/2009 | WO2009071449A1 Pyridylmethyl-sulfonamide compounds |
| 06/11/2009 | WO2009071448A1 Pyridylmethyl-sulfonamide compounds |
| 06/11/2009 | WO2009070869A1 Renin inhibitors |
| 06/11/2009 | WO2009070847A1 Compounds for therapy and diagnosis |
| 06/11/2009 | WO2009052264A3 Maleate salts of (e)-n-{4-[3-chloro-4-(2-pyridinylmethoxy)anilino]-3-cyano-7-ethoxy-6-quinolinyl}-4-(dimethylamino)-2-butenamide and crystalline forms thereof |
| 06/11/2009 | WO2009051718A3 Calcium receptor modulating agents |
| 06/11/2009 | WO2009009501A4 Non-basic melanin concentrating hormone receptor-1 antagonists and methods |
| 06/11/2009 | WO2008135524A3 Substituted anthranilamides and analogues, manufacturing and use thereof as medicaments |